GILEAD SCIENCES, INC. STOCK OPTION AGREEMENTStock Option Agreement • August 6th, 2020 • Gilead Sciences Inc • Biological products, (no disgnostic substances) • Delaware
Optionee further acknowledges, understands and agrees that in no event will shares of Common Stock acquired upon exercise of the option be delivered to Optionee in Malta; all shares acquired upon exercise of the Option will be maintained on Optionee’s behalf in the United States.
GILEAD SCIENCES, INC. RESTRICTED STOCK UNIT ISSUANCE AGREEMENTRestricted Stock Unit Issuance Agreement • August 6th, 2020 • Gilead Sciences Inc • Biological products, (no disgnostic substances) • Delaware
Participant further acknowledges, understands and agrees that in no event will Shares acquired upon vesting or settlement of the Award be delivered to Participant in Malta; all Shares acquired upon vesting or settlement of the Award will be maintained on Participant’s behalf in the United States.
May 4, 2020 Johanna Mercier Dear Johanna,Letter Agreement • August 6th, 2020 • Gilead Sciences Inc • Biological products, (no disgnostic substances)
This letter agreement is entered into between Gilead Sciences, Inc. (“Gilead”) and you to confirm the extension of certain relocation assistance benefits provided to you pursuant to the Offer Letter between you and Gilead dated May 21, 2019 (the “Offer Letter”).
